GG1978
Overview
GG1978 is a closed-ended investment fund focusing mainly on pharmaceuticals and biotechnologies. The Fund aims to combine an entrepreneurial approach with financial discipline, focusing on the development of strategic businesses, striving to improve their competitive position and profitability. The fund's goal is to generate long-term capital gains in both private and public companies, specializing in the human medicine, biotechnology, medical technology and diagnostics sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Colossal | Jan 2025 | Series C | Co-investor |
| 1000Farmacie | Jul 2023 | Series A Extension | Co-investor |
| ClexBio | Nov 2024 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is GG1978 based?
GG1978 is headquartered in Luxembourg, Canton of Luxembourg, Luxembourg.
When was GG1978 founded?
GG1978 was founded in 2022.
How many portfolio companies does GG1978 have?
GG1978 has 3 portfolio companies in Caplight's dataset.
What are some companies in GG1978's portfolio?
Portfolio companies visible on Caplight include Colossal, 1000Farmacie, ClexBio.
What was GG1978's most recent investment shown here?
GG1978's most recent investment in this portfolio sample was in Colossal in 2025.
What sectors does GG1978 focus on?
GG1978 focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does GG1978 focus on?
GG1978 typically invests at the Mid stage.
What is GG1978's AUM?
GG1978's assets under management are estimated between $50.0M and $100.0M.